2 July 2019 - Deborah Wilkes
Archived
Boiron has criticised a French recommendation on homoeopathy, Taisho Pharmaceutical has completed its planned acquisition of UPSA, and BioGaia has announced a deal with Abbott in Uruguay.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.